BRPI0814697A2 - dispositivo de liberação dérmica com uma vedação no local - Google Patents

dispositivo de liberação dérmica com uma vedação no local

Info

Publication number
BRPI0814697A2
BRPI0814697A2 BRPI0814697A BRPI0814697A BRPI0814697A2 BR PI0814697 A2 BRPI0814697 A2 BR PI0814697A2 BR PI0814697 A BRPI0814697 A BR PI0814697A BR PI0814697 A BRPI0814697 A BR PI0814697A BR PI0814697 A2 BRPI0814697 A2 BR PI0814697A2
Authority
BR
Brazil
Prior art keywords
seal
place
release device
dermal
dermal release
Prior art date
Application number
BRPI0814697A
Other languages
English (en)
Inventor
Kydonieus Agis
G Conway Robert
m rossi Thomas
Original Assignee
Agile Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agile Therapeutics Inc filed Critical Agile Therapeutics Inc
Publication of BRPI0814697A2 publication Critical patent/BRPI0814697A2/pt
Publication of BRPI0814697B1 publication Critical patent/BRPI0814697B1/pt
Publication of BRPI0814697B8 publication Critical patent/BRPI0814697B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00544—Plasters form or structure
    • A61F2013/00646—Medication patches, e.g. transcutaneous

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0814697A 2007-07-10 2008-07-10 dispositivo de liberação de fármacos BRPI0814697B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94875707P 2007-07-10 2007-07-10
US60/948,757 2007-07-10
PCT/US2008/069618 WO2009009649A1 (en) 2007-07-10 2008-07-10 Dermal delivery device with in situ seal

Publications (3)

Publication Number Publication Date
BRPI0814697A2 true BRPI0814697A2 (pt) 2017-06-06
BRPI0814697B1 BRPI0814697B1 (pt) 2020-11-17
BRPI0814697B8 BRPI0814697B8 (pt) 2021-05-25

Family

ID=40229053

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814697A BRPI0814697B8 (pt) 2007-07-10 2008-07-10 dispositivo de liberação de fármacos

Country Status (12)

Country Link
US (3) US8246978B2 (pt)
EP (1) EP2167002B1 (pt)
JP (2) JP5603235B2 (pt)
CN (1) CN101801321B (pt)
AU (1) AU2008275101B2 (pt)
BR (1) BRPI0814697B8 (pt)
CA (1) CA2692884C (pt)
EA (1) EA020208B1 (pt)
ES (1) ES2581652T3 (pt)
GE (1) GEP20125717B (pt)
NZ (1) NZ582565A (pt)
WO (1) WO2009009649A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292683A1 (en) 2000-09-15 2002-03-26 Bruder Healthcare Company Wound and therapy compress and dressing
US10105259B2 (en) 2000-09-15 2018-10-23 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
US9925087B2 (en) 2000-09-15 2018-03-27 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
US20100178323A1 (en) 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
US8246978B2 (en) 2007-07-10 2012-08-21 Agile Therapeutics, Inc. Dermal delivery device with reduced loss of its volatile components
WO2009009651A1 (en) * 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld
WO2009052491A2 (en) * 2007-10-18 2009-04-23 Geraghty, Erin Fenoldopam formulations and prodrug derivatives
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
WO2011088072A2 (en) * 2010-01-14 2011-07-21 Agile Therapeutics, Inc. Dermal delivery device
AU2010200556B2 (en) * 2010-02-15 2012-02-02 Oncobeta International Gmbh Brachytherapy method of treating skin tumours using a tailor-made radioactive source
WO2011118683A1 (ja) * 2010-03-25 2011-09-29 東洋化学株式会社 医用貼付剤
US20140243765A1 (en) * 2011-09-22 2014-08-28 Samyang Biopharmaceuticals Corporation Percutaneously absorbable preparation containing fentanyl and homologue thereof
PH12014501000A1 (en) 2011-11-04 2014-06-09 Agile Therapeutics Inc Dermal delivery compositions and methods
EP2806862A2 (en) 2012-01-27 2014-12-03 Agile Therapeutics, Inc. Transdermal hormone delivery
US9539201B2 (en) 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
EA030797B1 (ru) 2012-12-21 2018-09-28 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Система трансдермальной доставки гормонов (варианты) и способы ее применения
WO2014106014A1 (en) * 2012-12-28 2014-07-03 Noven Pharmaceuticals, Inc Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
WO2014143139A1 (en) 2013-03-15 2014-09-18 Bruder Healthcare Company Wound and therapy compress and dressing
EP2921184A1 (de) 2014-03-19 2015-09-23 LTS LOHMANN Therapie-Systeme AG Überpflaster mit verbesserter Verträglichkeit und einer langen Haftungsdauer und Verfahren zu seiner Herstellung
CA2981702A1 (en) * 2014-04-23 2015-10-29 Gregory Van Buskirk Cleaning formulations for chemically sensitive individuals: compositions and methods
EP3067050A1 (en) * 2015-03-13 2016-09-14 Acino AG Transdermal therapeutic system with an overtape comprising two adhesive layers
US10966936B2 (en) 2015-12-30 2021-04-06 Corium, Inc. Systems comprising a composite backing and methods for long term transdermal administration
JP7096591B2 (ja) * 2016-02-05 2022-07-06 パスポート テクノロジーズ、インコーポレイテッド 経皮透過物投与装置
US12156831B2 (en) 2016-03-01 2024-12-03 The Hilsinger Company Parent, Llc Therapeutic eye compress system
US12011388B2 (en) 2016-03-01 2024-06-18 The Hilsinger Company Parent, Llc Therapeutic thermal compress with phase-change material
US12029681B2 (en) 2016-03-01 2024-07-09 The Hilsinger Company Parent, Llc Therapeutic eye mask system
EP3453364B1 (en) * 2016-05-02 2022-08-24 Kobayashi Pharmaceutical Co., Ltd. Heat generator
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
US12226534B2 (en) 2016-07-06 2025-02-18 Agile Therapeutics, Inc. Transdermal packaging membranes
EP3490544A1 (en) 2016-07-27 2019-06-05 Corium International, Inc. Memantine transdermal delivery systems
CN116270551A (zh) 2016-07-27 2023-06-23 考里安有限责任公司 通过盐至中性药物原位转化的组合物、透皮贴剂及应用
WO2018022814A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
CN113248586B (zh) * 2021-04-23 2022-08-30 武汉大学 褐飞虱pib14蛋白及其编码基因在调控植物抗褐飞虱中的应用
KR20250054053A (ko) * 2023-01-04 2025-04-22 노바스테이지 파마슈티컬즈 (선전) 리미티드 리스페리돈 경피 투여 시스템 및 이의 제조 방법과 용도
US12514756B1 (en) 2024-10-08 2026-01-06 Covidien Lp Dermal patch and systems, kits, and methods associated therewith

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108614U (ja) * 1983-01-05 1984-07-21 久光製薬株式会社 貼付剤構造
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
JPS62212321A (ja) * 1986-03-14 1987-09-18 Tadashi Ijima 治療具
US4917676A (en) * 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
JPH01224312A (ja) * 1988-03-01 1989-09-07 Tadashi Ijima 治療具
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
JPH0794583B2 (ja) * 1989-12-15 1995-10-11 株式会社大塚製薬工場 高含水高分子ゲル
US5252588A (en) * 1990-04-27 1993-10-12 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5227169A (en) * 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5273756A (en) 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5268179A (en) 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
US6010715A (en) * 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5756117A (en) 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
US6024975A (en) * 1992-04-08 2000-02-15 Americare International Diagnostics, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US5714543A (en) * 1994-01-13 1998-02-03 Bristol-Myers Squibb Company Water soluble polymer additives for polyurethane-based pressure sensitive adhesives
JP3021661B2 (ja) * 1994-03-07 2000-03-15 セラテック・インコーポレーテッド 薬剤含有接着複合体の経皮放出デバイス
IL113034A (en) * 1994-04-05 2000-02-17 Astra Ab Topical dressing
US5851549A (en) * 1994-05-25 1998-12-22 Becton Dickinson And Company Patch, with system and apparatus for manufacture
WO1996019205A1 (en) * 1994-12-21 1996-06-27 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
CN2245437Y (zh) * 1995-08-24 1997-01-22 福祥纺织股份有限公司 皮肤贴片
ATE226816T1 (de) * 1996-07-03 2002-11-15 Alza Corp Vorrichtungen zur arzneistoffabgabe und herstellungsverfahren
KR100213465B1 (ko) * 1996-11-01 1999-08-02 최좌진 케토프로펜 패취 조성물
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
JP2000514065A (ja) * 1997-07-03 2000-10-24 アルザ コーポレイション ドラッグデリバリーディバイスとその製造法
US6086912A (en) * 1998-02-11 2000-07-11 Gilman; Marvin S. Topical drug delivery system
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US7045145B1 (en) * 1999-11-24 2006-05-16 Agile Therapeutics, Inc. Transdermal contraceptive delivery system and process
NZ516582A (en) * 2000-06-01 2004-08-27 Watson Pharmaceuticals Inc Transdermal delivery of lasofoxifene
AU2001292683A1 (en) 2000-09-15 2002-03-26 Bruder Healthcare Company Wound and therapy compress and dressing
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
EP1380622B1 (en) * 2001-03-08 2006-08-23 Matsushita Electric Industrial Co., Ltd. Inkjet recording ink, solvent for use in said ink and cartridge and recording device having said ink
US20040247640A1 (en) 2001-07-23 2004-12-09 Yi-Ju Zhao Nitric oxide releasing eptfe coated medical device sandwich
CA2453013C (en) * 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US7612248B2 (en) * 2002-12-19 2009-11-03 3M Innovative Properties Company Absorbent medical articles
WO2004075933A2 (en) * 2003-02-26 2004-09-10 Lavipharm S.A. Devices for releasing volatile substances and methods of producing the devices
CN1291759C (zh) * 2003-07-31 2006-12-27 天津大学 聚n－乙烯基吡咯烷酮与聚乙烯醇共混压敏胶及其应用
US20070037751A1 (en) * 2003-08-06 2007-02-15 Gastrotech Pharma A/S Uses of secretagogues like ghrelin in cancer cachexia and for stimulating appetite
CA2542778C (en) * 2003-10-28 2012-05-29 Noven Pharmaceuticals, Inc. Transdermal drug delivery composition
JP4809062B2 (ja) * 2004-01-30 2011-11-02 久光製薬株式会社 カバー材及びカバー材付き貼付剤
WO2005105061A2 (en) * 2004-04-14 2005-11-10 Indevus Pharmaceuticals, Inc. Transdermal patch
JP2006169160A (ja) * 2004-12-15 2006-06-29 Yuutoku Yakuhin Kogyo Kk 外用貼付剤およびその製造方法
EP1858495A2 (en) * 2005-02-14 2007-11-28 Neurogesx, Inc. Device for delivery of trpv1 agonists
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
AU2008208009B2 (en) 2007-01-22 2013-08-15 Passport Technologies, Inc. Transdermal porator and patch system and method for using same
WO2008148786A1 (en) 2007-06-04 2008-12-11 Coloplast A/S A method for manufacturing a patterned adhesive layer
US8246978B2 (en) 2007-07-10 2012-08-21 Agile Therapeutics, Inc. Dermal delivery device with reduced loss of its volatile components
WO2009009651A1 (en) * 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld

Also Published As

Publication number Publication date
EA020208B1 (ru) 2014-09-30
NZ582565A (en) 2012-07-27
WO2009009649A1 (en) 2009-01-15
CN101801321A (zh) 2010-08-11
ES2581652T3 (es) 2016-09-06
JP2010533199A (ja) 2010-10-21
US20140350493A1 (en) 2014-11-27
US20130018337A1 (en) 2013-01-17
EP2167002B1 (en) 2016-04-20
CA2692884A1 (en) 2009-01-15
AU2008275101B2 (en) 2014-08-21
US20100255072A1 (en) 2010-10-07
AU2008275101A1 (en) 2009-01-15
CA2692884C (en) 2016-09-20
US8747888B2 (en) 2014-06-10
EP2167002A4 (en) 2012-11-28
EP2167002A1 (en) 2010-03-31
JP5603235B2 (ja) 2014-10-08
GEP20125717B (en) 2012-12-25
JP6072725B2 (ja) 2017-02-01
HK1142798A1 (zh) 2010-12-17
EA201070123A1 (ru) 2010-06-30
US8246978B2 (en) 2012-08-21
CN101801321B (zh) 2014-07-02
BRPI0814697B8 (pt) 2021-05-25
BRPI0814697B1 (pt) 2020-11-17
JP2014159468A (ja) 2014-09-04

Similar Documents

Publication Publication Date Title
BRPI0814697A2 (pt) dispositivo de liberação dérmica com uma vedação no local
EP2281677A4 (en) LAMINATE FORM DEVICE
PT2268401T (pt) Ensaios
DK2239414T3 (da) Tætningsanordning
BRPI0818349A2 (pt) Dispositivo de reconstrução
BRPI0814324A2 (pt) Dispositivo
BRPI0822034A2 (pt) Dispositivo
GB0810719D0 (en) Polymeric film
BRPI0907259A2 (pt) Dispositivo em um engrenamento planetário e uma engrenagem planetária
NO20081244L (no) Ryggestotteanordning
BRPI0815136A2 (pt) Dispositivo de injeção
BRPI0819741A2 (pt) Aparelho de amarração
EP2126624A4 (en) DISPLAY
BRPI0913604A2 (pt) dispositivo de vedação
DE102008011876B8 (de) Anzeigevorrichtung
EP2287238A4 (en) HEAT SHRINKING POLYESTER FOIL
DE602009001221D1 (de) Abdichtungsvorrichtung
EP2289996A4 (en) FLUOR RESIN FILM
EP2187463A4 (en) Display apparatus
DE502008001742D1 (de) Kabelbearbeitungseinrichtung
EP2251719A4 (en) PEEL FILM
BRPI0915210A2 (pt) dispositivo de exibição
FR2925545B1 (fr) Nacelle de securite
EP2114655A4 (en) PLATE FOR MOLDING SYSTEM HAVING ANTI-TILT STRUCTURE
BRPI0820296A2 (pt) Dispositivo de exibição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/07/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF